Whole Blood Metabolomics in Aging Research

Int J Mol Sci. 2020 Dec 26;22(1):175. doi: 10.3390/ijms22010175.

Abstract

Diversity is observed in the wave of global aging because it is a complex biological process exhibiting individual variability. To assess aging physiologically, markers for biological aging are required in addition to the calendar age. From a metabolic perspective, the aging hypothesis includes the mitochondrial hypothesis and the calorie restriction (CR) hypothesis. In experimental models, several compounds or metabolites exert similar lifespan-extending effects, like CR. However, little is known about whether these metabolic modulations are applicable to human longevity, as human aging is greatly affected by a variety of factors, including lifestyle, genetic or epigenetic factors, exposure to stress, diet, and social environment. A comprehensive analysis of the human blood metabolome captures complex changes with individual differences. Moreover, a non-targeted analysis of the whole blood metabolome discloses unexpected aspects of human biology. By using such approaches, markers for aging or aging-relevant conditions were identified. This information should prove valuable for future diagnosis or clinical interventions in diseases relevant to aging.

Keywords: aging; antioxidant; fasting; frailty; metabolites; metabolomics; whole blood.

Publication types

  • Review

MeSH terms

  • Aging*
  • Animals
  • Biomarkers / blood*
  • Humans
  • Metabolome*

Substances

  • Biomarkers